These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9787884)

  • 1. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
    Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Blakeley JE; Phan SP; Williams A; Rush AJ
    Psychiatry Res; 1998 Jun; 79(1):31-42. PubMed ID: 9676824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol circadian rhythms during the menstrual cycle and with sleep deprivation in premenstrual dysphoric disorder and normal control subjects.
    Parry BL; Javeed S; Laughlin GA; Hauger R; Clopton P
    Biol Psychiatry; 2000 Nov; 48(9):920-31. PubMed ID: 11074230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome.
    Gurguis GN; Antai-Otong D; Vo SP; Blakeley JE; Orsulak PJ; Petty F; Rush AJ
    Neuropsychopharmacology; 1999 Feb; 20(2):162-76. PubMed ID: 9885796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
    Reed SC; Levin FR; Evans SM
    Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
    Lin IM; Tsai YC; Peper E; Yen CF
    J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature circadian rhythms during the menstrual cycle and sleep deprivation in premenstrual dysphoric disorder and normal comparison subjects.
    Parry BL; LeVeau B; Mostofi N; Naham HC; Loving R; Clopton P; Gillin JC
    J Biol Rhythms; 1997 Feb; 12(1):34-46. PubMed ID: 9104689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.
    Yen JY; Lin PC; Huang MF; Chou WP; Long CY; Ko CH
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder.
    Gingnell M; Morell A; Bannbers E; Wikström J; Sundström Poromaa I
    Horm Behav; 2012 Sep; 62(4):400-6. PubMed ID: 22814368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation.
    Barone JC; Ho A; Osborne LM; Eisenlohr-Moul TA; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Nov; 169():107145. PubMed ID: 39096755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    J Clin Endocrinol Metab; 2008 Jan; 93(1):96-102. PubMed ID: 17956950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder.
    Lin PC; Ko CH; Lin YJ; Yen JY
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder.
    Shechter A; Lespérance P; Ng Ying Kin NM; Boivin DB
    PLoS One; 2012; 7(12):e51929. PubMed ID: 23284821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes.
    Halbreich U; Piletz JE; Carson S; Halaris A; Rojansky N
    Biol Psychiatry; 1993 Nov; 34(10):676-86. PubMed ID: 7904832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder.
    Oral E; Ozcan H; Kirkan TS; Askin S; Gulec M; Aydin N
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):685-93. PubMed ID: 23455589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.